Singapore markets closed
Straits Times Index
3,301.78 +4.23 (+0.13%) S&P 500
5,483.50 +10.27 (+0.19%) Dow
38,883.63 +105.53 (+0.27%) Nasdaq
17,861.31 +4.29 (+0.02%) Bitcoin USD
64,653.99 -733.82 (-1.12%) CMC Crypto 200
1,348.82 -40.59 (-2.92%)
Calidi Biotherapeutics, Inc. (CLDI)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 09:45AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.52M |
| Enterprise value | 23.09M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 50.83 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 49.42 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.59 |
| 52-week change 3 | -98.13% |
| S&P500 52-week change 3 | 24.71% |
| 52-week high 3 | 13.7900 |
| 52-week low 3 | 0.1440 |
| 50-day moving average 3 | 0.2571 |
| 200-day moving average 3 | 1.6388 |
Share statistics
| Avg vol (3-month) 3 | 1.92M |
| Avg vol (10-day) 3 | 4.44M |
| Shares outstanding 5 | 64.19M |
| Implied shares outstanding 6 | 64.19M |
| Float 8 | 36.01M |
| % held by insiders 1 | 39.29% |
| % held by institutions 1 | 5.62% |
| Shares short (15 May 2024) 4 | 295.05k |
| Short ratio (15 May 2024) 4 | 0.16 |
| Short % of float (15 May 2024) 4 | 1.10% |
| Short % of shares outstanding (15 May 2024) 4 | 0.58% |
| Shares short (prior month 15 Apr 2024) 4 | 1.43M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -242.04% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -29.93M |
| Net income avi to common (ttm) | -29.98M |
| Diluted EPS (ttm) | -0.8400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.14M |
| Total cash per share (mrq) | 0.02 |
| Total debt (mrq) | 11.71M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.13 |
| Book value per share (mrq) | -0.41 |
Cash flow statement
| Operating cash flow (ttm) | -27.71M |
| Levered free cash flow (ttm) | -45.61M |
© 2024 Yahoo. All rights reserved.